Columbia redesigns E. coli ribosomes

Ribosomes are the cell’s protein factories. They are also about the last place you would expect to get away with a radical redesign. But a Columbia-led team has now rebuilt the E. coli ribosome so every ribosomal protein works without isoleucine, one of life’s standard 20 amino acids. (science.org) That is the real news here — not a tweak at the edges, but a rewrite of core translation machinery inside a living bacterium. ### What did they actually change? They targeted the bacterial ribosome, the machine that reads RNA and assembles proteins. In E. coli, that means 52 ribosomal proteins spread across the 30S and 50S subunits. (science.org) The team redesigned every one of those proteins to remove isoleucine residues entirely, then swapped the redesigned versions into cells. In total, that meant replacing 382 isoleucines across the ribosome. ### Why is isoleucine the amino acid they picked? Isoleucine was a plausible candidate because it often overlaps functionally with other hydrophobic amino acids, especially valine and leucine. Evolutionary sequence comparisons had already hinted that isoleucine is one of the less conserved canonical amino acids. (science.org) So the bet was: if any member of the standard 20 could be engineered away first, isoleucine might be it. ### Why is the ribosome the hard version? Because the ribosome is not just another protein. It is the machine that builds almost every protein in the cell. If one redesigned enzyme fails, a cell might limp along. (science.org) If ribosomal proteins fail, translation breaks. That is why this result lands — they did not just show a few isolated proteins can survive without isoleucine. They showed the central protein-making apparatus can. ### Why couldn’t they just swap Ile for Val? Turns out that naive substitution worked badly. The paper says they first changed isoleucine to valine or leucine in 39 essential or highly expressed proteins, and only about 43% of those variants still functioned in vivo. (science.org) So this was not a simple search-and-replace problem. Many sites needed compensatory mutations elsewhere in the same protein to preserve folding, packing, and activity. ### Where did AI actually help? The models were used as design tools, not magic oracles. The team used sequence models like ESM2 and MSA Transformer, plus structure-based tools including ProteinMPNN and AlphaFold2, to propose isoleucine-free protein variants that still looked foldable and functional. (science.org) Then they ran an iterative design-build-test cycle in cells. Basically, the models narrowed the search space enough that the wet-lab engineering became tractable. ### Did the cells still grow normally? Close enough to make people pay attention. The redesigned ribosome supported relative cellular fitness above 90% of wild type. (science.org) Separate coverage of the work also notes the resulting strain stayed genomically stable over more than 450 generations without obvious reversion back to the standard 20-amino-acid setup. That does not mean the project is finished, but it does mean the redesign is more than a fragile demo. ### Is this already a 19-amino-acid organism? Not fully in the broadest sense. The ribosome is the headline achievement, and the paper frames it as a roadmap toward a free-living cell with a 19-amino-acid alphabet. (science.org) The distinction matters — removing isoleucine from one core machine is different from removing it cleanly from every required function across the whole cell. But this is a major step because translation sits at the center of the problem. ### Why does synthetic biology care? Because once translation machinery becomes redesignable, the genetic code starts looking less fixed. A reduced amino-acid alphabet could help researchers probe why life settled on 20 building blocks in the first place. (science.org) Longer term, it could open more programmable cells — organisms with biochemistry simpler than natural life in some ways, but more engineerable in others. The bottom line is simple. Columbia’s team did not just mutate a bacterium. They showed that one of biology’s most conserved machines can be computationally redesigned to run on a smaller alphabet. That pushes synthetic biology a step closer to cells whose translation systems are engineered on purpose, rather than inherited as untouchable constants. (science.org)